Ronald Krauss
Children’s Hospital Oakland Research Institute
Ronald Krauss, M.D., is the director of atherosclerosis research at Children’s Hospital Oakland Research Institute and an adjunct professor at UCSF and UC Berkeley. His research focuses on lipid metabolism, having developed an assay to quantify low-density lipoprotein (LDL) particle size and concentration. His published work covers dietary effects on cardiometabolic disease and insulin sensitivity, statin responses, and the relationship between cholesterol regulation, genetics, and Alzheimer's disease.
38 claims checked on air: 2 context 2 overstated 33 supported 1 unverified 2 flagged
What they said on air - citing their own research
2 citing their own research
Genetic variants associated with high LDL are associated with increased heart disease risk, whereas genetic variants associated with HDL cholesterol levels are almost never associated with heart disease risk.
"genes associated with high LDL are associated with heart disease risk. That's a very important pathologic connection, because genes ultimately are the blueprint for our biology, and if the genes associated with high LDL are also associated with heart disease risk, it says that the LDL is really the causal agent. The genes associated with variation in HDL cholesterol have almost in every case not been associated with heart disease risk" (said at 0:15:27)
Extensive Mendelian randomization studies and human genetic analyses demonstrate that genetic variants associated with higher LDL cholesterol are consistently and causally associated with increased risk of coronary heart disease and myocardial infarction. In contrast, genetic variants that specifically raise or lower plasma HDL cholesterol (such as variants in LIPG or multi-SNP genetic risk scores specific to HDL-C) show no significant causal association with myocardial infarction risk, despite the inverse association observed in observational epidemiology.
- supports: Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. (Lancet (London, England) 2012) · cited 119x in the literature
"However, a 1 SD increase in HDL cholesterol due to genetic score was not associated with risk of myocardial infarction (OR 0·93, 95% CI 0·68-1·26, p=0·63). For LDL cholesterol, the estimate from observational epidemiology (a 1 SD increase in LDL cholesterol associated with OR 1·54, 95% CI 1·45-1·63) was concordant with that from genetic score (OR 2·13, 95% CI 1·69-2·69, p=2×10(-10))." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from ge… (European heart journal 2017) · cited 3974x in the literature
"Separate meta-analyses of over 200 prospective cohort studies, Mendelian randomization studies, and randomized trials including more than 2 million participants with over 20 million person-years of follow-up and over 150 000 cardiovascular events demonstrate a remarkably consistent dose-dependent log-linear association between the absolute magnitude of exposure of the vasculature to LDL-C and the risk of ASCVD" (abstract, results, passage verified)
pubmedfull study (doi)
Saturated fat intake increases large LDL particles rather than small, dense LDL particles in the majority of the population.
"we've shown that the form of LDL that increases with saturated fat is not the small LDL, but the large LDL. And in fact, that led me to question whether or not saturated fat was really an important factor in heart disease risk, because our studies did not show that it was increasing small LDL in the majority of the population." (said at 0:33:58)
Randomized dietary intervention studies and comprehensive reviews confirm that in the general population, increasing dietary saturated fatty acid intake predominantly elevates concentrations of large, buoyant LDL particles rather than small, dense LDL particles. A landmark crossover feeding trial by Krauss and colleagues showed that saturated fat intake was positively correlated with the mass of large LDL particles and inversely correlated with small, dense LDL particles. A state-of-the-art review in the Journal of the American College of Cardiology similarly concluded that while saturated fatty acids raise total LDL cholesterol, in most individuals this rise is driven by larger LDL particles rather than small, dense LDL subclasses.
- supports: Effects of a very high saturated fat diet on LDL particles in adults with atherogenic dysl… (PloS one 2017) · cited 129x in the literature
"Previous studies have shown that increases in LDL-cholesterol resulting from substitution of dietary saturated fat for carbohydrate or unsaturated fat are due primarily to increases in large cholesterol-enriched LDL, with minimal changes in small, dense LDL particles and apolipoprotein B." (abstract, background, passage verified)
pubmedfull study (doi) - supports: Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations: JAC… (Journal of the American College of Cardiology 2020) · cited 537x in the literature
"Although SFAs increase low-density lipoprotein (LDL) cholesterol, in most individuals, this is not due to increasing levels of small, dense LDL particles, but rather larger LDL particles, which are much less strongly related to CVD risk." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Change in dietary saturated fat intake is correlated with change in mass of large low-dens… (The American journal of clinical nutrition 1998) · cited 169x in the literature
"Changes in intake (ie, high fat minus low fat) of total saturated fatty acids, as well as myristic (14:0) and palmitic (16:0) acids, were positively correlated (P < 0.01) with increases in mass of large LDL particles [measured by analytic ultra-centrifugation as mass of lipoproteins of flotation rate (Sf) 7-12] and with LDL peak particle diameter and flotation rate, but not with changes in LDL-cholesterol concentration." (abstract, results, passage verified)
pubmedfull study (doi)
Fact-checked episodes
Publications
- Loss of TMEM55B modulates lipid metabolism through dysregulated lipophagy and mitochondrial function.Cell death & disease 2026 · CEBM Level 5
- Effects of Protein Source and Amount of Saturated Fat on Insulin Sensitivity, Insulin Secretion, and Disposition Index in Healthy Individuals.The Journal of nutrition 2026 · CEBM Level 2
- TOMM40 suppression promotes neuronal cholesterol imbalance and molecular and behavioral phenotypes of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association 2026 · CEBM Level 5
- Associations of plasma level of soluble LDL receptor with cardiovascular events and mortality in a large prospective cohort study.Lipids in health and disease 2026 · CEBM Level 3
- Broad-Spectrum Effects of Carbohydrate Reduction on Inflammatory and Immune Mediators in Type 2 Diabetes.Endocrine research 2026 · CEBM Level 3
- Beyond Lipidation: CSF APOE4 Protein Burden, Not HDL Subclass, Drives Tau Associations in APOE4 Alzheimer's Disease.Research square 2026 · CEBM Level 3
- Foods to Prevent Cardiometabolic Disease: Moving from "Saturated Fat" to "Whole Foods".Current developments in nutrition 2026 · CEBM Level 5
- TOMM40 '523' genotype induces sex- and tissue- specific differences in cholesterol and triglyceride levels in an APOE-TOMM40 humanized mouse model.bioRxiv : the preprint server for biology 2026 · CEBM Level 5
- Effect of Hormone Therapy on Lipoprotein Subfractions in Early and Late Postmenopausal Women.The Journal of clinical endocrinology and metabolism 2025 · CEBM Level 2
- GWAS of CRP response to statins further supports the role of APOE in statin response: A GIST consortium study.Pharmacological research 2025 · CEBM Level 3
- Cholesterol Variability and Dementia Risk: Finding Meaning in the Ups and Downs.Neurology 2025 · CEBM Level 5
- Independent associations of high-density lipoprotein cholesterol and triglyceride levels with Alzheimer's disease and related dementias.Alzheimer's & dementia : the journal of the Alzheimer's Association 2025 · CEBM Level 3
- SLCO1B1 Functional Variants, Bilirubin, Statin-Induced Myotoxicity, and Recent Sub-Saharan African Ancestry: A Precision Medicine Health Equity Study.Clinical pharmacology and therapeutics 2025 · CEBM Level 3
- Regular-fat and low-fat dairy foods and cardiovascular diseases: perspectives for future dietary recommendations.The American journal of clinical nutrition 2025 · CEBM Level 5
- Sociodemographic modifiers of effects of statin initiation on dementia incidence: An emulated trial design in a large health care member population with 10+ years of follow-up.Alzheimer's & dementia : the journal of the Alzheimer's Association 2025 · CEBM Level 3
- MIR192 Upregulates GLP-1 Receptor and Improves Statin-Induced Impairment of Insulin Secretion.bioRxiv : the preprint server for biology 2025 · CEBM Level 5
- Uncertainty in the estimated effects of statin initiation on risk of dementia: using a multiverse analysis to assess sources of variability.European journal of epidemiology 2025 · CEBM Level 3
- Response to "Comment on 'Independent associations of high-density lipoprotein cholesterol and triglyceride levels with Alzheimer's disease and related dementias' ".Alzheimer's & dementia : the journal of the Alzheimer's Association 2025 · CEBM Level 5
- Statin Initiation and Dementia Incidence in a Large Health Care System From 1997 to 2020: A Target Trial Emulation Study.Neurology 2025 · CEBM Level 3
- Polygenic prediction of body mass index and obesity through the life course and across ancestries.Nature medicine 2025 · CEBM Level 3
- Dietary Management of Atherogenic Dyslipidemia.Current atherosclerosis reports 2025 · CEBM Level 5
- Development and Application of an Algorithm for Statin-Induced Myopathy Based on Electronic Health Record-Derived Structured Elements.Pharmacoepidemiology and drug safety 2025 · CEBM Level 4
- Clinical validation of a statin-benefit polygenic score using real-world cohorts of primary prevention participants.medRxiv : the preprint server for health sciences 2025 · CEBM Level 3
- Targeting TOMM40 and TOMM22 to Rescue Statin-Impaired Mitochondrial Function, Dynamics, and Mitophagy in Skeletal Myotubes.International journal of molecular sciences 2025 · CEBM Level 5
- Changes in soluble LDL receptor and lipoprotein fractions in response to diet in the DIETFITS weight loss study.Journal of lipid research 2024 · CEBM Level 2
- Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial.Psychiatry research 2024 · CEBM Level 4
- X chromosome dosage drives statin-induced dysglycemia and mitochondrial dysfunction.Nature communications 2024 · CEBM Level 5
- Participant-derived cell line transcriptomic analyses and mouse studies reveal a role for ZNF335 in plasma cholesterol statin response.Genome medicine 2024 · CEBM Level 5
- TOMM40 regulates hepatocellular and plasma lipid metabolism via an LXR-dependent pathway.Molecular metabolism 2024 · CEBM Level 5
- The small HDL particle hypothesis of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association 2023 · CEBM Level 4
- Remnant lipoprotein particles and cardiovascular disease risk.Best practice & research. Clinical endocrinology & metabolism 2023 · CEBM Level 5
- VLDL receptor gene therapy for reducing atherogenic lipoproteins.Molecular metabolism 2023 · CEBM Level 5
- Development and application of an algorithm for statin-induced myopathy based on electronic health record-derived structured elements.medRxiv : the preprint server for health sciences 2023 · CEBM Level 3
- An association of CSF apolipoprotein E glycosylation and amyloid-beta 42 in individuals who carry the APOE4 allele.Alzheimer's research & therapy 2023 · CEBM Level 4
- Author Correction: The power of genetic diversity in genome-wide association studies of lipids.Nature 2023 · CEBM Level 3
- Participant-derived cell line transcriptomic analyses and mouse studies reveal a role for ZNF335 in plasma cholesterol statin response.bioRxiv : the preprint server for biology 2023 · CEBM Level 5
- TOMM40 and TOMM22 of the Translocase Outer Mitochondrial Membrane Complex rescue statin-impaired mitochondrial dynamics, morphology, and mitophagy in skeletal myotubes.bioRxiv : the preprint server for biology 2023 · CEBM Level 5
- Low- and High-Density Lipoprotein Cholesterol and Dementia Risk Over 17 Years of Follow-up Among Members of a Large Health Care Plan.Neurology 2023 · CEBM Level 3
- Missense variants in SORT1 are associated with LDL-C in an Amish population.Journal of lipid research 2023 · CEBM Level 4
- Correction: Randomized nutrient bar supplementation improves exercise-associated changes in plasma metabolome in adolescents and adult family members at cardiometabolic risk.PloS one 2023 · CEBM Level 2
- Identification of genetic drivers of plasma lipoprotein size in the Diversity Outbred mouse population.Journal of lipid research 2023 · CEBM Level 5
- Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2.Human molecular genetics 2022 · CEBM Level 3
- The microbial gbu gene cluster links cardiovascular disease risk associated with red meat consumption to microbiota L-carnitine catabolism.Nature microbiology 2022 · CEBM Level 3
- A gene-diet interaction controlling relative intake of dietary carbohydrates and fats.Molecular metabolism 2022 · CEBM Level 5
- Reply to A Drewnowski et al, O Devinsky, D A Booth and E L Gibson, and D J Millward.The American journal of clinical nutrition 2022 · CEBM Level 5
- The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.Clinical pharmacology and therapeutics 2022 · CEBM Level 5
- Small dense low-density lipoprotein particles: clinically relevant?Current opinion in lipidology 2022 · CEBM Level 5
- Concerns regarding NMR lipoprotein analyses performed on the Nightingale heath platform - Focus on LDL subclasses.Journal of clinical lipidology 2022 · CEBM Level 5
- A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation.Nature genetics 2022 · CEBM Level 3
- Lipoprotein subfractions and subclinical vascular health in middle aged women: does menopause status matter?Menopause (New York, N.Y.) 2022 · CEBM Level 3
- Modest effect of statins on fasting glucose in a longitudinal electronic health record based cohort.Cardiovascular diabetology 2022 · CEBM Level 3
- Polygenic Risk Score and Statin Relative Risk Reduction for Primary Prevention of Myocardial Infarction in a Real-World Population.Clinical pharmacology and therapeutics 2022 · CEBM Level 3
- Undifferentiated Induced Pluripotent Stem Cells as a Genetic Model for Nonalcoholic Fatty Liver Disease.Cellular and molecular gastroenterology and hepatology 2022 · CEBM Level 5
- Competing paradigms of obesity pathogenesis: energy balance versus carbohydrate-insulin models.European journal of clinical nutrition 2022 · CEBM Level 5
- A multi-layer functional genomic analysis to understand noncoding genetic variation in lipids.American journal of human genetics 2022 · CEBM Level 3
- Obesity and cardiovascular disease: beyond body weight and energy balance.European journal of preventive cardiology 2022 · CEBM Level 5
- A saturated map of common genetic variants associated with human height.Nature 2022 · CEBM Level 3
- Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research.Journal of clinical lipidology 2022 · CEBM Level 5
- Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis.Genome biology 2022 · CEBM Level 3
- An analysis of the recent US dietary guidelines process in light of its federal mandate and a National Academies report.PNAS nexus 2022 · CEBM Level 5
- Correction to: Impact of a 2‑year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes.Cardiovascular diabetology 2021 · CEBM Level 5
- A multi-ethnic genome-wide association study implicates collagen matrix integrity and cell differentiation pathways in keratoconus.Communications biology 2021 · CEBM Level 4
- Efficacy of AAV9-mediated SGPL1 gene transfer in a mouse model of S1P lyase insufficiency syndrome.JCI insight 2021 · CEBM Level 5
- Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin.Clinical pharmacology and therapeutics 2021 · CEBM Level 4
- A unified framework identifies new links between plasma lipids and diseases from electronic medical records across large-scale cohorts.Nature genetics 2021 · CEBM Level 3
- Effects of Palm Stearin versus Butter in the Context of Low-Carbohydrate/High-Fat and High-Carbohydrate/Low-Fat Diets on Circulating Lipids in a Controlled Feeding Study in Healthy Humans.Nutrients 2021 · CEBM Level 2
- The carbohydrate-insulin model: a physiological perspective on the obesity pandemic.The American journal of clinical nutrition 2021 · CEBM Level 5
- Alternative Dietary Patterns for Americans: Low-Carbohydrate Diets.Nutrients 2021 · CEBM Level 5
- Dietary Saturated Fats and Health: Are the U.S. Guidelines Evidence-Based?Nutrients 2021 · CEBM Level 5
- Fecal Microbiome Composition Does Not Predict Diet-Induced TMAO Production in Healthy Adults.Journal of the American Heart Association 2021 · CEBM Level 2
- The power of genetic diversity in genome-wide association studies of lipids.Nature 2021 · CEBM Level 3
- Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors.European journal of preventive cardiology 2020 · CEBM Level 5
- Expanding Precompetitive Multisector Collaborations to Advance Drug Development and Pharmacogenomics.Clinical pharmacology and therapeutics 2020 · CEBM Level 5
- Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study.The pharmacogenomics journal 2020 · CEBM Level 3
- Role of angiopoietin-like protein 3 in sugar-induced dyslipidemia in rhesus macaques: suppression by fish oil or RNAi.Journal of lipid research 2020 · CEBM Level 5
- The impact of adjusting for baseline in pharmacogenomic genome-wide association studies of quantitative change.NPJ genomic medicine 2020 · CEBM Level 4
- A Randomized Study of the Effect of Replacing Sugar-Sweetened Soda by Reduced Fat Milk on Cardiometabolic Health in Male Adolescent Soda Drinkers.Nutrients 2020 · CEBM Level 2
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.European heart journal 2020 · CEBM Level 5
- High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation.Metabolic syndrome and related disorders 2020 · CEBM Level 5
- Phosphatidylinositol-(4,5)-Bisphosphate Regulates Plasma Cholesterol Through LDL (Low-Density Lipoprotein) Receptor Lysosomal Degradation.Arteriosclerosis, thrombosis, and vascular biology 2020 · CEBM Level 5
- Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.Journal of clinical lipidology 2020 · CEBM Level 4
- Lipoprotein Particle Predictors of Arterial Stiffness after 17 Years of Follow Up: The Malmö Diet and Cancer Study.International journal of vascular medicine 2020 · CEBM Level 3
- Public health guidelines should recommend reducing saturated fat consumption as much as possible: NO.The American journal of clinical nutrition 2020 · CEBM Level 5
- Public health guidelines should recommend reducing saturated fat consumption as much as possible: Debate Consensus.The American journal of clinical nutrition 2020 · CEBM Level 5
- Public health guidelines should recommend reducing saturated fat consumption as much as possible: YES.The American journal of clinical nutrition 2020 · CEBM Level 5
- Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations: JACC State-of-the-Art Review.Journal of the American College of Cardiology 2020 · CEBM Level 5
- Genetic variants modulate gene expression statin response in human lymphoblastoid cell lines.BMC genomics 2020 · CEBM Level 5
- Randomized nutrient bar supplementation improves exercise-associated changes in plasma metabolome in adolescents and adult family members at cardiometabolic risk.PloS one 2020 · CEBM Level 2
- Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes.Cardiovascular diabetology 2020 · CEBM Level 3
- Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2020 · CEBM Level 5
- Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women.European heart journal 2019 · CEBM Level 2
- Single-molecule 3D imaging of human plasma intermediate-density lipoproteins reveals a polyhedral structure.Biochimica et biophysica acta. Molecular and cell biology of lipids 2019 · CEBM Level 5
- Fructose-induced hypertriglyceridemia in rhesus macaques is attenuated with fish oil or ApoC3 RNA interference.Journal of lipid research 2019 · CEBM Level 5
- Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial.Alimentary pharmacology & therapeutics 2019 · CEBM Level 3
- Low-Density Lipoprotein Particle Size Subfractions and Cerebral Amyloidosis.Journal of Alzheimer's disease : JAD 2019 · CEBM Level 4
- A randomized, controlled trial on the effects of almonds on lipoprotein response to a higher carbohydrate, lower fat diet in men and women with abdominal adiposity.Lipids in health and disease 2019 · CEBM Level 2
- Low plasma adropin concentrations increase risks of weight gain and metabolic dysregulation in response to a high-sugar diet in male nonhuman primates.The Journal of biological chemistry 2019 · CEBM Level 5
- Evaluation of commonly used ectoderm markers in iPSC trilineage differentiation.Stem cell research 2019 · CEBM Level 5
- ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance.Journal of lipid research 2019 · CEBM Level 5
- Effects of red meat, white meat, and nonmeat protein sources on atherogenic lipoprotein measures in the context of low compared with high saturated fat intake: a randomized controlled trial.The American journal of clinical nutrition 2019 · CEBM Level 2
- Lessons Learned from the POUNDS Lost Study: Genetic, Metabolic, and Behavioral Factors Affecting Changes in Body Weight, Body Composition, and Cardiometabolic Risk.Current obesity reports 2019 · CEBM Level 5
- Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss.JCI insight 2019 · CEBM Level 2
- WHO draft guidelines on dietary saturated and trans fatty acids: time for a new approach?BMJ (Clinical research ed.) 2019 · CEBM Level 5
- ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways.FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2019 · CEBM Level 5
- PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction.Journal of lipid research 2018 · CEBM Level 5
- A large electronic-health-record-based genome-wide study of serum lipids.Nature genetics 2018 · CEBM Level 3
- Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content.PLoS biology 2018 · CEBM Level 5
- LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins.Circulation 2018 · CEBM Level 4
- Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.European heart journal 2018 · CEBM Level 5
- Dietary fat and cardiometabolic health: evidence, controversies, and consensus for guidance.BMJ (Clinical research ed.) 2018 · CEBM Level 5
- Comparability of Lipoprotein Particle Number Concentrations Across ES-DMA, NMR, LC-MS/MS, Immunonephelometry, and VAP: In Search of a Candidate Reference Measurement Procedure for apoB and non-HDL-P Standardization.Clinical chemistry 2018 · CEBM Level 4
- ZNF542P is a pseudogene associated with LDL response to simvastatin treatment.Scientific reports 2018 · CEBM Level 5
- Metagenomic Insights into the Degradation of Resistant Starch by Human Gut Microbiota.Applied and environmental microbiology 2018 · CEBM Level 2
- Characterization of Statin Low-Density Lipoprotein Cholesterol Dose-Response Using Electronic Health Records in a Large Population-Based Cohort.Circulation. Genomic and precision medicine 2018 · CEBM Level 3
- Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders.American journal of human genetics 2018 · CEBM Level 3
- Impact of Individual Traits, Saturated Fat, and Protein Source on the Gut Microbiome.mBio 2018 · CEBM Level 2
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.European heart journal 2017 · CEBM Level 5
- Assessing the mechanisms of cholesteryl ester transfer protein inhibitors.Biochimica et biophysica acta. Molecular and cell biology of lipids 2017 · CEBM Level 5
- Impact of Dietary Resistant Starch on the Human Gut Microbiome, Metaproteome, and Metabolome.mBio 2017 · CEBM Level 2